---
title: "Penicillamine Tablets USP 250 mg, 100-count bottle, Rx Only, Manufactured for... — FDA record D-0148-2024 | Is It on Recall"
description: "Failed Dissolution Specifications"
url: https://isitonrecall.com/recall/fda-drug-d-0148-2024-penicillamine-tablets-usp-250-mg-100-count-bottle-rx-only-manufactured-for-lupin-pharmaceuticals-inc/
updated: 2026-10-01
site: "Is It on Recall"
language: en
---

[Recall archive](https://isitonrecall.com/archives/) / FDA drug enforcement

# Penicillamine Tablets USP 250 mg, 100-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore,... — FDA record D-0148-2024

Reported terminated

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Nov 22, 2023. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/).

## What the record says

- **Product**: Penicillamine Tablets USP 250 mg, 100-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202 Manufactured by: Lupin Limited, Nagpur-441 108, India, NDC# 70748-153-01
- **Reason**: Failed Dissolution Specifications
- **Classification**: Class II
- **Recalling firm**: Lupin Pharmaceuticals Inc.
- **Quantity**: N/A
- **Agency-reported status**: Terminated
- **Source record identifier**: D-0148-2024

[Open the official record](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0148-2024%22)

[What the recall classes mean](https://isitonrecall.com/guides/recall-classes/). Classification is an agency assessment, not individual medical advice.

## Lot and product identifiers

| Label field | Details supplied by the agency |
| --- | --- |
| Lot, code or applicability | Lot # M200498, Exp. June 2024 |

Match all identifying details in the current notice. A brand name alone is not enough.

## Distribution

Product was distributed to 3 wholesale/distributor accounts.

No US distribution state could be established from this record. Check the official notice.

## Dates in the source

- **Report date**: Dec 20, 2023
- **Recall initiation date**: Nov 22, 2023
- **Center classification date**: Dec 13, 2023
- **Termination date**: Jul 8, 2024

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

## What to do next

Read the official notice for the action that applies to your exact product.

[Read the current instructions](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0148-2024%22)

## Before changing a medicine

Follow urgent instructions in the current official recall notice. Speak to your pharmacist or prescriber before stopping or changing a prescribed medicine.

Talk to your doctor or pharmacist if you have questions or concerns about your medicine. [FDA medication recall guidance](https://www.fda.gov/drugs/drug-recalls/understanding-drug-recalls-what-know-and-what-do)

## Related records

[Medications records](https://isitonrecall.com/category/medications/) [Lupin Pharmaceuticals Inc. records](https://isitonrecall.com/brand/lupin-pharmaceuticals-inc/)